Beiträge zum Schlagwort:

ROS1

Immuno-OncologyVeröffentlicht am: 13. Okt. 2017

The role of immunotherapy for patients with rare mutations

The role of immunotherapy for patients with uncommon EGFR mutations, ROS1 and C-MET who express PD-L1 is still unclear.